Surge In Livestock Population Drives Growth In The Foot And Mouth Disease Vaccine Market: A Key Catalyst Accelerating Foot And Mouth Disease Vaccine Market Growth in 2025

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

Foot And Mouth Disease Vaccine Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, there has been a significant expansion in the market size for the foot and mouth disease vaccine. Projected growth for this market suggests an increase from $2.61 billion in 2024, escalating to $2.84 billion in 2025, alluding to a compound annual growth rate (CAGR) of 8.9%. Factors responsible for the growth observed during the historical period can be traced back to the development of multivalent vaccines, the prevalence of foot and mouth disease, government-driven initiatives to control the disease, heightened emphasis on food security, the economic ramification of FMD outbreaks, coupled with investments in research and development efforts.

Foot And Mouth Disease Vaccine Market Size Forecast: What's the Projected Valuation by 2029?
In the coming years, the market size for the foot and mouth disease vaccine is anticipated to expand rapidly. It is projected to reach $4.17 billion by 2029, growing at a compound annual growth rate (CAGR) of 10.1%. Factors contributing to growth during this forecast period encompass the effects of climate change on disease proliferation, the emergence of novel FMD strains, the one health approach, the digitalization of vaccine distribution, improvements in vaccine cold chain infrastructure, ongoing enhancements in vaccine safety, and the involvement with precision livestock farming, plus international aid for vaccination programs. Significant trends during this period are expected to include worldwide initiatives to eradicate FMD, the creation of multivalent vaccines, collaborations between public and private sectors, advances in diagnostic and surveillance technologies, biotech breakthroughs, genomic surveillance, and the uptake of marker vaccines.

View the full report here:
https://www.thebusinessresearchcompany.com/report/foot-and-mouth-disease-vaccine-global-market-report

What Are the Drivers Transforming the Foot And Mouth Disease Vaccine Market?
The escalation in the number of livestock is a key contributing factor to the growth of the foot and mouth disease vaccine market. Livestock, which encompasses farm animals such as cows, horses, and pigs, are bred and cared for by humans. This increase in livestock numbers is due to a surge in the demand for animal products. The growth in livestock could potentially result in the spread of foot and mouth disease, thereby stimulating the market's growth. For example, a 2022 report from the US Department of Agriculture revealed that the national cattle herd of India grew from 1.2 million in 2021 to an astounding 306.7 million in 2022. Consequently, the rise in livestock population is expected to fuel the foot and mouth disease vaccine market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8522&type=smp

What Long-Term Trends Will Define the Future of the Foot And Mouth Disease Vaccine Market?
One prominent trend in the foot-and-mouth disease vaccine market is the strategic partnership. Key market players are partnering up to utilize shared resources and venture into new markets. For example, in July 2022, Argentina's Biogénesis Bagó, renowned for its specialization in foot-and-mouth disease vaccines, collaborated with FVC to develop a state-of-the-art FMD vaccine facility in South Korea. This strategic alliance will allow South Korea to access advanced technologies, thereby enabling the delivery of safe, high-quality FMD vaccines to their domestic market. It will also facilitate the creation of cost-effective solutions for local livestock farmers, thereby aiding in the preservation of the nation's sanitary status. FVC is an information technology services provider based in South Korea.

Which Segments in the Foot And Mouth Disease Vaccine Market Offer the Most Profit Potential?
The foot and mouth disease vaccine market covered in this report is segmented -

1) By Vaccine Type: Conventional Vaccines, Oil Based Vaccines, Aluminum Hydroxide Or Saponin Based Vaccines, Emergency Vaccines
2) By Animal Type: Cattle, Pig, Sheep And Goat, Other Animals
3) By Distribution Channel: Government Organizations, Distributors Or Pharmacies, Private Vet, Other Distribution Channels

Subsegments:
1) By Conventional Vaccines: Inactivated Whole Virus Vaccines, Live Attenuated Vaccines, Oil-Based Vaccines
2) By Oil-Based Vaccines: Oil Emulsion Vaccines, Oil Adjuvanted Vaccines, Aluminum Hydroxide OrSaponin Based Vaccines
3) By Aluminum Hydroxide Or Saponin Based Vaccines: Aluminum Hydroxide Adjuvanted Vaccines, Saponin Adjuvanted Vaccines
4) By Emergency Vaccines: DIVA (Differentiating Infected From Vaccinated Animals) Vaccines, Rapid Response Vaccines

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=8522&type=smp

Which Firms Dominate the Foot And Mouth Disease Vaccine Market by Market Share and Revenue in 2025?
Major companies operating in the foot and mouth disease vaccine market are Godrej Agrovet Limited, Biogénesis Bagó S.A., Indian Immunologicals Limited, Limor de Colombia, Merck & Co. Inc., Brilliant Bio Pharma Ltd., Intervet India Private Limited, Biovet Private Limited, China Animal Husbandry Group, C.H. Boehringer Sohn AG & Co. KG, VECOL S.A, VETAL Animal Health Products Inc., The Spirit Jinyu Biological Pharmaceutical Co. Ltd., Dong Bang Co. Ltd., FGBI-ARRIAH, NAVETCO NATIONAL VETERINARY JOINT STOCK COMPANY, Ceva Santé Animale, MEVAC, Agrovet Market S.A., Alivira Animal Health Limited, Southern Cross Group, SPIC Gene Science Technology Development Co. Ltd., Zoetis Inc.

Which Regions Offer the Highest Growth Potential in the Foot And Mouth Disease Vaccine Market?
Asia-Pacific was the largest region in the foot and mouth disease vaccine market in 2024. The regions covered in the foot and mouth disease vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8522

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.